Contact Us

Beilu Pharma Dispatches Its First Shipment of Contrast Media to the EU

2026/10/23


On October 22, 2026, Beilu Pharma held a ceremony at its Miyun pharmaceutical plant to mark the dispatch of its first shipment of contrast media for the European Union market.


The shipment follows the company's successful on-site EU Good Manufacturing Practice (GMP) inspection in 2024 and the completion of EU-market registration verification and approval procedures in 2025. Beilu's R&D, production, quality, supply chain, and overseas marketing teams worked together throughout the process, applying EU pharmaceutical quality standards and rigorous checks at every stage to secure market access.



beilu-pharma-first-eu-contrast-media-shipment.webp


With trucks loaded and ready to depart, the shipment marks an important milestone in bringing Beilu Pharma's contrast media to the EU market and advancing the company's internationalization strategy.

Building on this milestone, Beilu Pharma will continue to uphold pharmaceutical quality standards, steadily expand its global presence, and serve patients overseas with high-quality pharmaceutical products.

PREV : No information

References
Related Products
Related Beilu News